Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of cell-free DNA in lymphomas: from sample collection to genotyping and minimal residual disease monitoring.

Blood advances - 22 Sept 2026

Piffaretti Deborah, Consoli Chiara, Rossi Davide

Abstract excerpt

ABSTRACT: Circulating tumor DNA (ctDNA) is increasingly investigated in lymphomas because it enables noninvasive molecular profiling, longitudinal assessment of clonal evolution, and quantification of minimal residual disease (MRD), which reflects residual tumor burden and treatment response and serves as a clinically validated prognostic biomarker. The clinical utilities of ctDNA include supporting diagnosis,...

Read the complete abstract on PubMed

Topics

Humans
Neoplasm, Residual
Lymphoma
Circulating Tumor DNA
Genotyping Techniques
Genotype
Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Specimen Handling

High-Throughput Nucleotide Sequencing

Cell-Free Nucleic Acids

Source

Open in PubMed Open full text

Identifiers

PMID: 42284698
DOI: 10.1182/bloodadvances.2024015609
PMCID: PMC13616811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of cell-free DNA in lymphomas: from sample collection to genotyping and minimal residual disease monitoring.PMID 42284698Read ↗

Circulating Tumor DNA in Lymphoma.Semantic proximity Read ↗

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational researchSemantic proximity Read ↗

Circulating Tumor DNA in Lymphoma: Principles and Future DirectionsSemantic proximity Read ↗

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.Semantic proximity Read ↗

Liquid biopsy in lymphoma: Molecular methods and clinical applications.Semantic proximity Read ↗

Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature ReviewSemantic proximity Read ↗

Clinical applications of cell-free DNA-based liquid biopsy analysisSemantic proximity Read ↗

Clinical use of circulating tumor DNA analysis in patients with lymphomaSemantic proximity Read ↗

High-throughput sequencing for noninvasive disease detection in hematologic malignanciesSemantic proximity Read ↗

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity Read ↗

[Progression and application of circulating tumor DNA in lymphoma].Semantic proximity Read ↗

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.